Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis - XML Representation

Raw xml | Download


<EvidenceVariable xmlns="http://hl7.org/fhir">
  <id value="179784"/>
  <meta>
    <versionId value="3"/>
    <lastUpdated value="2023-12-01T22:26:01.820Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 179784</b></p><a name="179784"> </a><a name="hc179784"> </a><a name="179784-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 3; Last updated: 2023-12-01 22:26:01+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-group-assignment.html">GroupAssignment</a></p></div><p><b>url</b>: <a href="https://fevir.net/resources/EvidenceVariable/179784">https://fevir.net/resources/EvidenceVariable/179784</a></p><p><b>identifier</b>: FEvIR Object Identifier/179784</p><p><b>name</b>: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis</p><p><b>title</b>: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19</p>
</div><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td><a href="CodeSystem-179423.html#179423-evidence-communication">Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication</a>: Evidence Communication</td><td><span title="Codes:">group-assignment</span></td></tr></table><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style="display: none">*</td><td>Cite As</td><td><div><p>GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.</p>
</div></td></tr></table><h3>Definitions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-handling-and-category}">Defined in handling and category elements</span></td></tr></table><p><b>handling</b>: dichotomous variable</p><blockquote><p><b>category</b></p><p><b>name</b>: Therapeutic-dose anticoagulation with heparin</p><p><b>value</b>: <a href="Group-179786.html">ExposureDefinition: Therapeutic-dose anticoagulation with heparin</a></p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: Usual-care pharmacologic thromboprophylaxis</p><p><b>value</b>: <a href="Group-179785.html">ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis</a></p></blockquote></div>
  </text>
  <url value="https://fevir.net/resources/EvidenceVariable/179784"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net"/>
    <value value="179784"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name
        value="Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis"/>
  <title
         value="GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis"/>
  <status value="active"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19"/>
  <useContext>
    <code>
      <system value="https://fevir.net/resources/CodeSystem/179423"/>
      <code value="evidence-communication"/>
      <display value="Evidence Communication"/>
    </code>
    <valueCodeableConcept>
      <text value="group-assignment"/>
    </valueCodeableConcept>
  </useContext>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <author>
    <name value="Brian S. Alper"/>
  </author>
  <relatedArtifact>
    <type value="cite-as"/>
    <citation
              value="GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784."/>
  </relatedArtifact>
  <definition>
    <concept>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="defined-in-handling-and-category"/>
        <display value="Defined in handling and category elements"/>
      </coding>
    </concept>
  </definition>
  <handling value="dichotomous"/>
  <category>
    <name value="Therapeutic-dose anticoagulation with heparin"/>
    <valueReference>🔗 
      <reference value="Group/179786"/>
      <type value="Group"/>
      <display
               value="ExposureDefinition: Therapeutic-dose anticoagulation with heparin"/>
    </valueReference>
  </category>
  <category>
    <name value="Usual-care pharmacologic thromboprophylaxis"/>
    <valueReference>🔗 
      <reference value="Group/179785"/>
      <type value="Group"/>
      <display
               value="ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis"/>
    </valueReference>
  </category>
</EvidenceVariable>